STRATegy SUccesS in High-Risk PCI With Impella CP: Evaluation of Hemodynamic Protection in Complex PCI

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRayyan Hemetsberger

About this trial

STRATUS-PCI is a pilot clinical trial that compares two ways of running a small heart pump called Impella CP during a high-risk procedure to open blocked heart arteries (percutaneous coronary intervention, or PCI) in patients with weakened heart muscle. The pump is placed temporarily through an artery in the leg and sits across the aortic valve to help maintain blood flow during the procedure.

Fifty patients will be randomly assigned in equal numbers to one of two pump settings: an automatic mode that adjusts flow up to higher levels as needed, or a fixed lower-flow mode (P-2). The doctor performing the heart procedure will not know which setting is being used (double-blind). A separate doctor monitors blood pressure and is allowed to change the pump setting at any time if the patient becomes unstable.

The main question is whether the automatic mode helps doctors complete the planned heart procedure more successfully and without drops in blood pressure or other complications. Results will help design a larger future trial.

Eligibility criteria

Qualifiers

signed written informed consent

age ≥ 18 years

presentation in chronic coronary syndrome or acute coronary syndrome (STEMI ≥ 24h)

Disqualifiers

no written informed consent

pregnancy

acute infection

recent ST-elevation myocardial infarction (< 24 hours) or not normalized CK-MB enzymes

Trial design

Treatments tested in this trial

  • Impella CP

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Rayyan Hemetsberger

Lead sponsor

Medical University of Vienna

Sponsor institution